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A loss-of-function polymorphism in 
the osmoregulatory TRPV4 channel 
associates with hyponatremia
Tian et al., Proc Natl Acad Sci USA 2009; 106: 14034–14039; doi:10.1073/
pnas.0904084106
Osmolality is among the most tightly regulated properties of 
body water. Abnormal osmolality in humans can be associ-
ated with neurological dysfunction and death, with even subtle 
changes in systemic osmolality inducing defects in coordina-
tion and cognition. Yet, hyponatremia, reflecting excess of water 
relative to total body sodium, is the most common electrolyte 
abnormality in hospitalized patients. Needless to say, water 
balance in mammals is regulated by the interaction of thirst 
and the renal water-conserving role of vasopressin. Secre-
tion of vasopressin from the posterior pituitary is controlled 
by the hypothalamic osmoreceptors, where transient receptor 
potential channel 4 (TRPV4), located in the circumventricular 
organs, constitutes an important component of the sensor of 
low osmolality. TRPV4 is a Ca2+-permeable cation channel that 
is activated by cell swelling. TRPV4 participates in the regu-
lation of vasopressin release, and mice with targeted deletion 
of the TRPV4 gene have markedly impaired osmoregulation. 
The mice have an exaggerated vasopressin secretory response 
to increases in osmolality, and thus TRPV4 appears to trans-
mit a negative signal for vasopressin secretion. In a recent pub-
lication, Tian et al. examined the association between serum 
sodium concentration and a non-synonymous single-nucleotide 
polymorphism (SNP) in the TRPV4 gene. This polymorphism, 
rs3742030, gives rise to a nonconservative amino acid substi-
tution (that is, Pro to Ser) at residue 19. Furthermore, it was 
the only TRPV4 non-synonymous SNP for which minor-allele 
frequency was reported in the International HapMap data set. 
The authors used banked genomic DNA from a panel of healthy 
elderly subjects to genotype for the presence of the allele and 
found that, among Caucasian and African-American subjects, 
the TRPV4P19S allele was overrepresented in subjects with the 
lowest serum sodium concentrations. The polymorphism was 
significantly associated with serum sodium concentration and 
with hyponatremia (serum sodium concentration ≤135 mequiv. 
per liter). Moreover, the average serum sodium concentration 
was lower among subjects with the TRPV4P19S allele relative to 
the wild-type allele, and subjects with the minor allele were two 
to six times as likely to exhibit hyponatremia as subjects with-
out it. Consistent with these observations, the human TRPV4 
channel with the TRPV4P19S polymorphism showed diminished 
response to hypotonic stress (Figure), while the response to a 
phorbol ester TRPV4 agonist (4αPDD) was unaffected. These in 
vivo and in vitro results strongly suggest that this TRPV4 poly-
morphism affects channel function in humans, thus influencing 
systemic water balance on a population-wide basis.
Qais Al-Awqati
Secretin regulates  
water homeostasis
Chu et al., Proc Natl Acad Sci USA 2009; 106: 15961–15966; doi:10.1073/
pnas.0903695106
It has long been known that the neurohypophysis secretes 
two peptide hormones, vasopressin and oxytocin. The two 
peptides, which differ by a single amino acid, are synthesized 
within the magnocellular neurosecretory cells in the paraven-
tricular nucleus and supraoptic nucleus. Oxytocin is best known 
for its role in parturition and lactation, whereas vasopressin is 
critical for renal water conservation. However, several studies 
suggest the presence of vasopressin-independent mechanisms 
of renal water conservation. For example, some patients diag-
nosed with the syndrome of inappropriate antidiuretic hor-
mone (SIADH) and who have low renal clearance of free water 
have undetectable plasma vasopressin. Moreover, studies in 
the vasopressin-deficient Brattleboro rat indicated the exist-
ence of vasopressin-independent mechanisms for regulation of 
aquaporin-2 membrane insertion. Recent research demonstrated 
that secretin, a hormone that modulates water and electrolyte 
transport in pancreatic ductal cells, liver cholangiocytes, and 
epididymal epithelial cells, also stimulates aquaporin-2 trans-
location from intracellular vesicles to the plasma membrane in 
renal medullary tubules. Furthermore, secretin receptor−null 
mice developed modest mild polydipsia and polyuria as well as 
reduced renal expression of aquaporins 2 and 4. Hence, Chu et 
al. examined a putative role of secretin as a potential hormone 
involved in control of water balance. During chronic hyperosmo-
lality, they found increased plasma secretin levels (Figure) as well 
as intense secretin immunoreactivity in the posterior pituitary. 
They also found that secretin is present throughout the hypoth-
alamo-neurohypophysial axis and that it is released from the 
posterior pituitary under plasma hyperosmolality. Interestingly, 
in the hypothalamus, secretin stimulated vasopressin expression 
and release. These results, along with previous observations that 
secretin regulates renal water reabsorption, indicate that this 
hormone has multiple sites of action in the regulation of water 
metabolism. Whether abnormalities in secretin regulation will 
The TRPV4P19S allele is hypofunctioning in vitro. Time courses for 
whole-cell currents at two different voltages (−100 mV and +100 mV) 
in HEK293 cells transfected with human TRPV4WT (a) and TRPV4P19S 
(b) first activated by 15% hypotonicity and then by the phorbol ester 
4α-phorbol 12,13-didecanoate (4αPDD). 
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illuminate long-standing and unexplained clinical observations 
in patients with hyponatremia remains to be determined.
Juan Oliver
Intrahepatic fat, not visceral fat,  
is linked with metabolic 
complications of obesity
Fabbrini et al., Proc Natl Acad Sci USA 2009; 106: 15430–15435; 
doi:10.1073/pnas.0904944106
The significance of visceral adipose tissue for obesity-related 
metabolic disorders is well established. Reducing visceral fat has 
become a key goal in obesity management, since it is correlated 
with intrahepatic triglyceride content. Therefore, Fabbrini et al. 
explored whether intrahepatic fat is a better marker of metabolic 
abnormalities of obesity than visceral fat. They determined the 
independent association of intrahepatic and visceral fat with met-
abolic function by evaluating groups of obese subjects who dif-
fered in intrahepatic fat content (high or normal) but matched for 
visceral fat volume, or who differed in visceral fat volume (high or 
low) but matched for intrahepatic fat content. The study used stable 
isotope tracer techniques and the euglycemic–hyperinsulinemic 
clamp procedure to assess insulin sensitivity and very-low-density 
lipoprotein–triglyceride (VLDL-TG) secretion rate. The authors 
found that hepatic, adipose tissue, and muscle insulin sensitivity 
were significantly lower, while the VLDL-TG secretion rate was 
almost twice as high, in subjects with higher than normal intrahe-
patic fat content, even when matched for visceral fat. In contrast, 
the investigators observed no differences in insulin sensitivity or 
VLDL-TG secretion between subjects with different visceral fat 
volumes when matched for intrahepatic fat content.
On the basis of these data, the authors suggest that intrahepatic 
fat may be a better marker of the metabolic derangements asso-
ciated with obesity than visceral fat. Furthermore, alterations in 
tissue fatty acid transport could be involved in the pathogenesis 
of ectopic triglyceride accumulation by redirecting plasma fatty 
acid uptake from adipose tissue toward other tissues. These con-
siderations may be of interest in understanding the metabolic 
syndrome and differences in fat distribution observed in patients 
with chronic renal diseases.
Detlef Schlöndorff
Meta-analysis:  
retinal vessel caliber  
and risk for coronary heart disease
McGeechan et al., Ann Intern Med 2009; 151: 404–413
Nephrologists are aware of the association between micro-
albuminuria and cardiovascular outcomes. Epidemiologic 
studies have examined a potentially similar relationship 
between retinal vessel caliber and cardiovascular outcomes 
but have not provided consistent results. Although most stud-
ies do suggest some association, the associations vary among 
subgroups based on age and sex. This meta-analysis used 
patient-level data from six population-based cohort studies 
to evaluate the association between retinal vessel diameter and 
cardiovascular outcomes, dissecting the differences among 
these subgroups. These studies measured retinal vessel caliber 
from photos using computer-assisted methods, recorded inci-
dent cardiovascular events, and contributed patient-level data 
to this analysis. Nonfatal cardiovascular events were defined 
as the composite of myocardial infarction, coronary artery 
bypass graft surgery, or coronary angioplasty.
In models adjusted for age, decreasing arteriolar caliber 
and increasing venular caliber were associated with a signifi-
cant risk of a composite coronary event in women (hazard 
ratio (HR)=1.18, 95% confidence interval (CI) 1.09–1.29, 
and HR=1.26, 95% CI 1.16–1.37, respectively). In an age-
adjusted model in men, the hazard was less (HR=1.06, 95% CI 
0.98–1.14, and HR=1.12, 95% CI 1.04–1.20, for arteriolar and 
venular caliber, respectively). In the model adjusted for case 
mix, clinical and laboratory variables, and known risk factors 
for coronary events, the hazard ratio associated with decreas-
ing arteriolar caliber was 1.17 (95% CI 1.07–1.28) in women 
and 1.02 (95% CI 0.94–1.10) in men. In the fully adjusted 
models, increasing venular caliber was associated with a haz-
ard ratio of 1.16 (95% CI 1.06–1.26) in women and 1.02 (95% 
CI 0.95–1.10) in men. Further analysis within sexes suggests 
that risk varies on the basis of comorbidities in women. In 
women without hypertension or diabetes, the risk associated 
with a decreasing arteriolar and increasing venular caliber 
was greater than among women with these comorbidities. No 
substantive difference was seen among men.
This relationship between retinal vessel caliber and cardio-
vascular events is not likely to replace current risk stratifi-
cation methods because of the heterogeneity of association 
among subgroups and the logistics of obtaining these meas-
urements. However, this relationship adds to our understand-
ing of the differences in heart and kidney disease progression 
between sexes. Whether the differential relationship repre-
sents alternative pathobiology or whether sex is a marker of a 
factor such as body size where the true difference exists can-
not be determined. Regardless, the differences in progression 
and outcomes in heart disease may be related to or marked by 
changes at the macrovascular level.
Lynda Szczech
Effects of chronic hyperosmolality on plasma secretin levels. SCT, secretin.
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